Overview

Comparative Bioavailability of Risperidone.

Status:
Completed

Trial end date:
2021-09-17

Target enrollment:

Participant gender:

Summary

This is an Open-Label, One-Sequence Study to Evaluate the Steady- State Comparative Bioavailability of Intramuscular Risperidone ISM® and EU Risperdal® (Sourced From Germany).

Phase:

Phase 1

Details

Lead Sponsor:

Rovi Pharmaceuticals Laboratories

Treatments:

Risperidone